US Pharmaceutical Market
The value of the US medical device market was $116.2 billion in 2008, and is expected to register a CAGR of 5.0% to reach an estimated $209.7 billion in 2020.
Dallas, TX (PRWEB) March 27, 2015
The report “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US” is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the US. The population of the US in 2013 amounted to 316.1 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.8% from 2008. The country’s increasingly elderly population and corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was worth $326.9 billion in 2008, a value that is expected to have reached $548.4 billion by 2020 at a CAGR of 4.4%. Approximately 86.6% of the US population has healthcare coverage, which has helped to create an efficient healthcare system. New initiatives taken by the Food and Drug Administration (FDA) have strengthened the review and approval process. The value of the US medical device market was $116.2 billion in 2008, and is expected to register a CAGR of 5.0% to reach an estimated $209.7 billion in 2020. Complete report available @ http://www.rnrmarketresearch.com/countryfocus-healthcare-regulatory-and-reimbursement-landscape-us-market-report.html .
The report identifies key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical devices markets.
These growth trends can be primarily attributed to -
- Sedentary lifestyles, leading to a high chronic disease burden
- High public healthcare expenditure by the Centers for Medicare and Medicaid Services (CMS)
- Increased R&D expenditure
- Easily accessible diagnostic technologies
Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99677 . (This is a premium report priced at US$1995 for a single user License.)
The report provides information on the healthcare, regulatory, and reimbursement landscape in the US, and includes - An overview of the pharmaceutical and medical device markets, including market size, segmentation, and key drivers and barriers; Profiles and SWOT analyses of the major players in the pharmaceuticals market: Pfizer, Merck, Novartis, Sanofi and Abbott; and profiles and SWOT analyses of the major players in the medical device market: Medtronic, DePuy, Siemens Healthcare, Abbott Laboratories, and Stryker; Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices; Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure; An overview of the opportunities for and challenges to growth in the healthcare market.
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the US healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect the US healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in the US healthcare market
Table of Contents
1 Table of Contents
2 Introduction
3 Overview of Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.2 Medical Device Market
3.3 Market Drivers and Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.2 Regulatory Landscape
5 Country Analysis
5.1 Political Environment
5.2 Economic Landscape
5.3 Economic Indicators
5.4 Demographics
5.5 Healthcare Infrastructure
5.6 Healthcare Expenditure
5.7 Trade Associations
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
Explore more reports on Regulation & Policy at http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/regulation-policy .
About Us:
RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.